Guidance for sustainable glove purchasing

Description

Gloves are the highest-volume disposable product purchased by health care. Glove use has increased dramatically and is expected to nearly double in the next five years. As health care facilities rethink their purchasing and supply chains in the wake of COVID-19, this guidance can serve as a roadmap for advancing sustainable options in the marketplace.

Our recommendations 

  • Avoid gloves containing polyvinyl chloride (PVC) and powdered latex.
  • Replace them with more sustainable alternatives that meet labor standards without compromising patient safety or care.

 

Resources
Member Content

Glove purchasing considerations

How to establish your purchasing priorities

Develop a contract clause with your supplier that sets goals and timelines, and requires reports on progress toward the achievement of desired environmental and social criteria. 

  • Reduce unnecessary waste of gloves through packaging improvement (i.e. when taking a glove out of the package, others should not fall out)  A study in Sweden showed that  6% of gloves were lost due to poor packaging, increasing costs, and waste.
  • The supplier/bidder should report the results of completed Code of Conduct audits of factories that manufacture gloves. The audit should be no more than 2-years old and be performed according to established methods such as SA8000, SMETA IV pillar, BSCI, etc.
  • The purchaser/tenderer should report which risks have been identified in the audit and how these risks have been assessed in the supply chain for offered gloves
  • At the start of the contract, the manufacturer should specify the constituent substances that have either been added during manufacture or are already known to be included in the product; as accelerators or antioxidants that are known to cause health effects based on available data (see "Chemicals and allergens in the manufacture of disposable gloves").  
  • The product should not include chemicals that have a harmonized classification as skin sensitizers under the Classification, Labelling and Packaging (CLP) Regulation such as chromium VI, nickel, and cobalt compounds. See ECHA announcement and Annex XV proposing restrictions on skin sensitizing substances, Table 19 pages 108-128)
  • The weight of gloves should be standardized and disclosed. Products with the lowest unit weight value should be preferred while meeting quality standards
  • Information should be provided on the availability of environmental management systems (its scope should include the manufacturing process of the product), for example, ISO 14001.
  • Documentation should be provided regarding greenhouse gas emissions (carbon footprint must include scope 1, 2, and 3 emissions and third-party verification). The bidder should specify the methods used (scope includes the manufacturing process of the product), for example, disclosure through the Carbon Disclosure Project (CDP) or others using the Greenhouse Gas Protocol.

Materials

Gloves purchasing guidance materials chart 2021
Source: Adapted from Joint Commission Environment of Care and OSHA PPE Guidance

 

Target criteria

Work with your supplier to procure gloves that meet the following criteria. 

Top priority

  • Include contract clause to monitor contract adherence to social and environmental requirements and address non-compliance with contract requirements 
  • Performance requirements specific to regulatory requirements, region, and use. 
  • Gloves that are sterilized should use gamma radiation for sterilization 

Product content

  • For surgical gloves: The product does not include the accelerant diphenyl guanidine (DPG) (CAS 102-06-7)
  • The product does not contain polyvinyl chloride (PVC)
  • The product does not contain di (2-ethylhexyl phthalate) (DEHP). The total concentration must not exceed 0.1% by weight (1000 mg / kg) in any separate part of the offered equipment. 
  • The product should not contain phthalates, esters of orthophthalic acid, at concentrations above 50 ppm (50 mg/kg) per substance  
  • The product is not be treated with or intentionally contain biocidal chemicals  
  • All disposable gloves offered should be free of powder residue and the powder level in the gloves should not exceed 2 mg / glove. (Meets the U.S. Federal Drug Administration (FDA) Rule 81 FR 91722 ban of powder in gloves.)
  • Substances intended to moisturize or soften the hands are not added or found in the offered products.
  • The product is free of substances of high concern. The products offered do not contain substances listed on the current candidate list (Article 59 of Regulation [EC] No 1907/2006 on the Registration, Evaluation, Authorization and Restriction of Chemicals [REACH] in concentrations above 0.1% by weight [1,000 mg/kg] per substance). 
  • The product does not contain added Bisphenol A (CAS No. 80-05-7) and its structural analogs. Impurities/residues should not be present in amounts over 0.01% by weight (100 mg/kg) in any individual part of the product
  • The supplier will provide a list of accelerants and other allergens contained in the product (e.g. thiurams, dithiocarbamates, thiazoles) 

Packaging

  • The packaging does not contain PVC 
  • Non-sterile glove packaging does not contain any plastic polymers
  • The packaging shall be reduced to the extent possible, made of recycled material and recyclable, and Forest Service Certified certified or equivalent for paper products 

Supply chain considerations

  • The supplier will provide the addresses of all manufacturing sites involved in the manufacturing 
  • The buyer has the right to conduct audits, scheduled or unscheduled
  • The contract will be performed in accordance with the International Labour Organization’s (ILO) eight core conventions (forced labor, child labor, discrimination, freedom of association, and the right to organize (Nos. 29, 87, 98, 100, 105, 111, 138, and 182). The supplier will ensure that the conditions are met by subcontractors

Product databases

Purchasers will need to speak with suppliers directly about the criteria to identify compliant options. The following product databases can serve as good starting points to find sustainable gloves, but do not necessarily reflect gloves that meet these criteria.

Considerations

Usage 

  • Hand hygiene is the most critical intervention to protect against pathogens and health  care-acquired infections
  • Choose gloves that are appropriate for their intended use. Glove selection and usage guidance provide more information on how to select the right glove for the task. For example, the barrier protection required of biologics, radioactive material, or chemicals must be matched with the appropriate glove material. 
  • Gloves are only one component of hand hygiene. They should be used only where they have been demonstrated to reduce contamination for either the practitioner or the patient.
  • Gloves should not be used for routine duties. For example, you do not need to wear gloves to administer solid medication. Instead, practitioners should use the aseptic non–touch technique.
  • Gloves should be removed immediately after a procedure to prevent cross-contamination. Hands should then be decontaminated. 
  • Evidence suggests that gloves can be used inappropriately in clinical practice. Improper use of non-sterile gloves can lead to cross-contamination and has been implicated in infection outbreaks. Gloves are often used when they aren’t needed, put on too early, taken off too late, or not changed at critical points. 
  • Research shows that patients often feel uncomfortable with inappropriate use of gloves for personal tasks.

Sterile vs. non-sterile gloves

Sterile and non-sterile (exam) gloves each have a distinct purpose. 

Sterile gloves are used to protect the patient from the practitioner 

Non-sterile gloves are used to protect the patient, practitioner, or other users, when there is direct contact with hazardous chemicals, body fluids, non-intact skin, or where contact with mucous membranes is anticipated.

Occupational health and allergy concerns  

  • Half of all health care workers may experience dermatitis in any year.  Approximately 1 in 5 nurses develop hand dermatitis – a painful, debilitating condition that may require staff to be moved out of clinical areas. 
  • Allergenic ingredients in gloves can cause Type 1 and Type 3 hypersensitivity reactions, depending on the agent. It is important to diagnose the allergic reaction correctly to choose the appropriate gloves for the practitioner
    • For latex gloves: closely monitor allergy concerns including information on protein content in latex gloves and the extent of powdered content in all gloves.
    • Some practitioners may be allergic to the accelerants used in many gloves.
  • Some components of gloves can pose a threat to patients and workers.
    • Ortho-phthalates are added to PVC and other plastics to impart flexibility. They are used in many products so exposure is widespread, and can be cumulative. Adverse effects include hormone disruption, reproductive and developmental impacts, and kidney toxicity. Exposure to some ortho-phthalates is associated with an increased risk of asthma.
    • Some biocides used in gloves can be dangerous or toxic to humans and the environment and can accelerate the development of resistance to bacteria.
    • Many gloves are made with accelerants like thiurams, thiazoles, and carbamates that are contact allergens and can cause skin irritation and/or sensitization.

Environment and health

  • Reducing glove use where possible eliminates the resources and waste associated with unnecessary use.
  • Gloves are the highest volume disposable product purchased by health care. Its use has increased dramatically and is expected to nearly double in the next five years.
  • Manufacture and transport of gloves require resources and energy and require the use of chemicals of concern. 
  • Glove disposal results in waste that, if handled improperly, can threaten health.
  • A pilot project in the United Kingdom’s National Health Service showed glove use could be dramatically reduced with significant savings and carbon reduction while maintaining infection prevention and improving care.  
  • Some materials used to manufacture gloves can be toxic throughout their life cycle
  • The manufacture and disposal of gloves can threaten surrounding communities and workers.
  • Recycling PVC is challenging and can hinder the recycling of other kinds of plastic

Ethical 

Recent reports have documented worker exploitation around glove manufacture including forced labor, poor working conditions, and debt bondage.  The U.S. Customs and Border Protection agency barred some products from being distributed in the country after finding "reasonable evidence" that the companies were using forced labor. Allegations of abuse in glove production also include passport confiscations, illegal withholding of pay, and restricted freedom of movement.

As a result, it is important to: 

  • Research glove sourcing
  • Require suppliers to have effective risk management regarding workers' rights in accordance with the ILO's core conventions in their operations and in the supply chain of subcontractors who directly participate in fulfilling the contract​​​​​​

Innovation needed

This is an active area of research. Researchers, suppliers, manufacturers, and purchasers should continue to learn more and better understand the specific chemicals being used in gloves and to strive to find and bring into production safer alternatives.

  • Develop new non-fossil fuel-based materials 
  • Eliminate accelerants in the final products.
  • Optimize manufacturing to reduce material used (for example reduce weight and thickness) while maintaining high-performance standards.
  • Create circular systems to recover and recycle gloves and to manufacture gloves that are easily recyclable (observe circular economy and extended producer responsibility principles).
  • Create high-performing gloves that can be reused. 
  • Life cycle methodologies and quality differ from manufacturer to manufacturer.  Innovation is needed to improve, standardize and strengthen life-cycle analyses. 

Learn more

Case studies

Health Care Without Harm and the United Nations Development Programme (UNDP) acknowledge the funding for this work from Swedish International Development Cooperation Agency (Sida). The authors are solely responsible for this document. The views expressed do not represent the official views of Sida or UNDP.

Join Practice Greenhealth

Practice Greenhealth is the health care sector’s go-to source for information, tools, data, resources, and expert technical support on sustainability initiatives that help hospitals and health systems meet their health, financial, and community goals.

Join now